Insights into the structure and mechanism of action of the anti-candidal lectin Mo-CBP2 and evaluation of its synergistic effect and antibiofilm activity

Autor: João Xavier da Silva Neto, Lucas Pinheiro Dias, Larissa Alves Lopes de Souza, Helen Paula Silva da Costa, Ilka Maria Vasconcelos, Mirella Leite Pereira, José Tadeu Abreu de Oliveira, Claudia Johana Pérez Cardozo, Luiz Francisco Wemmenson Gonçalves Moura, Jeanlex Soares de Sousa, Rômulo Farias Carneiro, Tiago Deiveson Pereira Lopes, Daniele de Oliveira Bezerra de Sousa

Publikováno v: Process Biochemistry. 121:661-673

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::12ceb6be21560593ff9970f9279c37a9
https://doi.org/10.1016/j.procbio.2022.08.004

Skin fibroblasts from patients with type 1 diabetes (T1D) can be chemically transdifferentiated into insulin-expressing clusters: a transgene-free approach.

Autor: Federico Pereyra-Bonnet, María L Gimeno, Nelson R Argumedo, Marcelo Ielpi, Johana A Cardozo, Carla A Giménez, Sung-Ho Hyon, Marta Balzaretti, Mónica Loresi, Patricia Fainstein-Day, León E Litwak, Pablo F Argibay

Publikováno v: PLoS ONE, Vol 9, Iss 6, p e100369 (2014)

The conversion of differentiated cells into insulin-producing cells is a promising approach for the autologous replacement of pancreatic cells in patients with type 1 diabetes (T1D). At present, cellular reprogramming strategies encompass ethical pro

Externí odkaz: https://doaj.org/article/d9dd9b23694d426caa0c1df6aa3f4827

Skin fibroblasts from patients with type 1 diabetes (T1D) can be chemically transdifferentiated into insulin-expressing clusters: a transgene-free approach

Autor: Johana A. Cardozo, Pablo Argibay, Maria Laura Gimeno, Marcelo Ielpi, Monica Loresi, Nelson R. Argumedo, León Litwak, Marta Balzaretti, F. Pereyra-Bonnet, Patricia Fainstein-Day, Sung-Ho Hyon, Carla Alejandra Gimenez

Publikováno v: PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e100369 (2014)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

The conversion of differentiated cells into insulin-producing cells is a promising approach for the autologous replacement of pancreatic cells in patients with type 1 diabetes (T1D). At present, cellular reprogramming strategies encompass ethical pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a52657461b9114f368d688b7d724a2
https://pubmed.ncbi.nlm.nih.gov/24963634